company background image
2603 logo

Shijiazhuang Yiling Pharmaceutical XSEC:002603 Stock Report

Last Price


Market Cap







14 Jun, 2024


Company Financials +

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

XSEC:002603 Stock Report

Market Cap: CN¥28.8b

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shijiazhuang Yiling Pharmaceutical
Historical stock prices
Current Share PriceCN¥17.24
52 Week HighCN¥27.25
52 Week LowCN¥17.21
1 Month Change-13.10%
3 Month Change-20.00%
1 Year Change-35.48%
3 Year Change-13.71%
5 Year Change101.81%
Change since IPO36.44%

Recent News & Updates

Recent updates

Shareholder Returns

2603CN PharmaceuticalsCN Market

Return vs Industry: 002603 underperformed the CN Pharmaceuticals industry which returned -11.9% over the past year.

Return vs Market: 002603 underperformed the CN Market which returned -15.5% over the past year.

Price Volatility

Is 2603's price volatile compared to industry and market?
2603 volatility
2603 Average Weekly Movement3.0%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 002603's share price has been volatile over the past 3 months.

Volatility Over Time: 002603's weekly volatility (3%) has been stable over the past year.

About the Company

199213,958Xiang Jun

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for respiratory health, cardiovascular disease, diabetes mellitus, oncology, urologic disease, sleep-improving, and anti-aging. The company also provides dietary supplements, health food and drinks, disinfection products, and personal protective equipment, as well as formula granules.

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Fundamentals Summary

How do Shijiazhuang Yiling Pharmaceutical's earnings and revenue compare to its market cap?
2603 fundamental statistics
Market capCN¥28.80b
Earnings (TTM)CN¥453.79m
Revenue (TTM)CN¥8.91b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2603 income statement (TTM)
Cost of RevenueCN¥4.28b
Gross ProfitCN¥4.63b
Other ExpensesCN¥4.17b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)0.27
Gross Margin51.95%
Net Profit Margin5.10%
Debt/Equity Ratio11.9%

How did 2603 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.